241 related articles for article (PubMed ID: 27925349)
1. Hepatitis C viraemia reversibly maintains subset of antigen-specific T-bet+ tissue-like memory B cells.
Chang LY; Li Y; Kaplan DE
J Viral Hepat; 2017 May; 24(5):389-396. PubMed ID: 27925349
[TBL] [Abstract][Full Text] [Related]
2. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells.
Li H; Borrego F; Nagata S; Tolnay M
J Immunol; 2016 May; 196(10):4064-74. PubMed ID: 27076679
[TBL] [Abstract][Full Text] [Related]
3. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
Comarmond C; Garrido M; Pol S; Desbois AC; Costopoulos M; Le Garff-Tavernier M; Si Ahmed SN; Alric L; Fontaine H; Bellier B; Maciejewski A; Rosenzwajg M; Klatzmann D; Musset L; Poynard T; Cacoub P; Saadoun D
Gastroenterology; 2017 Jun; 152(8):2052-2062.e2. PubMed ID: 28274850
[TBL] [Abstract][Full Text] [Related]
4. TLR9 signalling in HCV-associated atypical memory B cells triggers Th1 and rheumatoid factor autoantibody responses.
Comarmond C; Lorin V; Marques C; Maciejewski-Duval A; Joher N; Planchais C; Touzot M; Biard L; Hieu T; Quiniou V; Desbois AC; Rosenzwajg M; Klatzmann D; Cacoub P; Mouquet H; Saadoun D
J Hepatol; 2019 Nov; 71(5):908-919. PubMed ID: 31279905
[TBL] [Abstract][Full Text] [Related]
5. Peripheral CD27-CD21- B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis.
Doi H; Tanoue S; Kaplan DE
Clin Immunol; 2014 Feb; 150(2):184-91. PubMed ID: 24434272
[TBL] [Abstract][Full Text] [Related]
6. T-bet-mediated Tim-3 expression dampens monocyte function during chronic hepatitis C virus infection.
Yi W; Zhang P; Liang Y; Zhou Y; Shen H; Fan C; Moorman JP; Yao ZQ; Jia Z; Zhang Y
Immunology; 2017 Mar; 150(3):301-311. PubMed ID: 27809352
[TBL] [Abstract][Full Text] [Related]
7. Skewed B cells in chronic hepatitis C virus infection maintain their ability to respond to virus-induced activation.
Oliviero B; Mantovani S; Ludovisi S; Varchetta S; Mele D; Paolucci S; Baldanti F; Mondelli MU
J Viral Hepat; 2015 Apr; 22(4):391-8. PubMed ID: 25258145
[TBL] [Abstract][Full Text] [Related]
8. Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections.
Oliviero B; Cerino A; Varchetta S; Paudice E; Pai S; Ludovisi S; Zaramella M; Michelone G; Pugnale P; Negro F; Barnaba V; Mondelli MU
J Hepatol; 2011 Jul; 55(1):53-60. PubMed ID: 21145853
[TBL] [Abstract][Full Text] [Related]
9. T-bet-expressing B cells during HIV and HCV infections.
Knox JJ; Kaplan DE; Betts MR
Cell Immunol; 2017 Nov; 321():26-34. PubMed ID: 28739077
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of B lymphocytes with a naive, resting phenotype in a subset of hepatitis C patients.
Ni J; Hembrador E; Di Bisceglie AM; Jacobson IM; Talal AH; Butera D; Rice CM; Chambers TJ; Dustin LB
J Immunol; 2003 Mar; 170(6):3429-39. PubMed ID: 12626604
[TBL] [Abstract][Full Text] [Related]
11. CD4+ CXCR5+ T cells in chronic HCV infection produce less IL-21, yet are efficient at supporting B cell responses.
Spaan M; Kreefft K; de Graav GN; Brouwer WP; de Knegt RJ; ten Kate FJ; Baan CC; Vanwolleghem T; Janssen HL; Boonstra A
J Hepatol; 2015 Feb; 62(2):303-10. PubMed ID: 25281860
[TBL] [Abstract][Full Text] [Related]
12. B-cell subset alterations and correlated factors in HIV-1 infection.
Pensieroso S; Galli L; Nozza S; Ruffin N; Castagna A; Tambussi G; Hejdeman B; Misciagna D; Riva A; Malnati M; Chiodi F; Scarlatti G
AIDS; 2013 May; 27(8):1209-17. PubMed ID: 23343911
[TBL] [Abstract][Full Text] [Related]
13. [Study of the correlation between elevated level of T-bet expression and liver damage in peripheral plasma cells of patients with autoimmune hepatitis].
Tan KA; Shi WW; Miao L; Dong XQ; Yang WN; Zhao H; Wang Y; Wang GQ; Hou FQ; Hong Y
Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):541-546. PubMed ID: 31357781
[No Abstract] [Full Text] [Related]
14. A prospective study of T- and B-lymphocyte subpopulations, CD81 expression levels on B cells and regulatory CD4(+) CD25(+) CD127(low/-) FoxP3(+) T cells in patients with chronic HCV infection during pegylated interferon-alpha2a plus ribavirin treatment.
Soldevila B; Alonso N; Martínez-Arconada MJ; Morillas RM; Planas R; Sanmartí AM; Martínez-Cáceres EM
J Viral Hepat; 2011 Jun; 18(6):384-92. PubMed ID: 20487258
[TBL] [Abstract][Full Text] [Related]
15. Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset.
Charles ED; Brunetti C; Marukian S; Ritola KD; Talal AH; Marks K; Jacobson IM; Rice CM; Dustin LB
Blood; 2011 May; 117(20):5425-37. PubMed ID: 21421840
[TBL] [Abstract][Full Text] [Related]
16. Features and distribution of CD8 T cells with human leukocyte antigen class I-specific receptor expression in chronic hepatitis C.
Bonorino P; Leroy V; Dufeu-Duchesne T; Tongiani-Dashan S; Sturm N; Pernollet M; Vivier E; Zarski JP; Marche PN; Jouvin-Marche E
Hepatology; 2007 Nov; 46(5):1375-86. PubMed ID: 17668887
[TBL] [Abstract][Full Text] [Related]
17. Vdelta1 T lymphocytes expressing a Th1 phenotype are the major gammadelta T cell subset infiltrating the liver of HCV-infected persons.
Agrati C; D'Offizi G; Narciso P; Abrignani S; Ippolito G; Colizzi V; Poccia F
Mol Med; 2001 Jan; 7(1):11-9. PubMed ID: 11474123
[TBL] [Abstract][Full Text] [Related]
18. Antibody production and in vitro behavior of CD27-defined B-cell subsets: persistent hepatitis C virus infection changes the rules.
Racanelli V; Frassanito MA; Leone P; Galiano M; De Re V; Silvestris F; Dammacco F
J Virol; 2006 Apr; 80(8):3923-34. PubMed ID: 16571809
[TBL] [Abstract][Full Text] [Related]
19. Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C.
Langhans B; Braunschweiger I; Arndt S; Schulte W; Satoguina J; Layland LE; Vidovic N; Hoerauf A; Oldenburg J; Sauerbruch T; Spengler U
Clin Sci (Lond); 2010 Apr; 119(2):97-109. PubMed ID: 20222873
[TBL] [Abstract][Full Text] [Related]
20. Naïve CD4+ T Cell Lymphopenia and Apoptosis in Chronic Hepatitis C Virus Infection Is Driven by the CD31+ Subset and Is Partially Normalized in Direct-Acting Antiviral Treated Persons.
Auma AWN; Shive CL; Lange A; Damjanovska S; Kowal C; Zebrowski E; Pandiyan P; Wilson B; Kalayjian RC; Canaday DH; Anthony DD
Front Immunol; 2021; 12():641230. PubMed ID: 33912168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
